<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04776759</url>
  </required_header>
  <id_info>
    <org_study_id>Rythmo20200901</org_study_id>
    <nct_id>NCT04776759</nct_id>
  </id_info>
  <brief_title>Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry</brief_title>
  <acronym>YOUNG-AF</acronym>
  <official_title>Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation is a rare cardiac arrhythmia in young (i.e. &lt;= 35-year-old) patients.&#xD;
      Etiological factors, current management and mid- to long-term outcomes remain unknown.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrial Fibrillation in YOUNG patients (YOUNG-AF) is a prospective, observational,&#xD;
      multicentric registry, including every consecutive patients aged &lt; 35-year-old with a&#xD;
      diagnosis of atrial fibrillation. The registry will assess demographical, physical activity,&#xD;
      toxicologic and genetic factors, as well as current management regarding anticoagulation,&#xD;
      anti-arrhythmic drugs and catheter ablation. As an observational registry, patient will be&#xD;
      managed with the guidelines-directed standard-of-care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2031</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2031</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Composite of mortality, thromboembolic event and heart failure</measure>
    <time_frame>at 10-year</time_frame>
    <description>Incidence of all-cause mortality, symptomatic thromboembolic event and congestive heart failure at 10-year after initial diagnosis of atrial fibrillation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrent symptomatic atrial fibrillation.</measure>
    <time_frame>at 10-year</time_frame>
    <description>Incidence of symptomatic atrial fibrillation at 10-year after initial diagnosis of atrial fibrillation.</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Lone Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Young patients (i.e. &lt; or = to 35-year-old) at the time of first atrial fibrillation&#xD;
        episode.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First episode of atrial fibrillation&#xD;
&#xD;
          -  Less than 35-year-old&#xD;
&#xD;
          -  Diagnostic by 12-lead ECG or continuous monitoring (minimal duration 30 seconds)&#xD;
&#xD;
          -  French Social Security number&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Transvenous cardiac implantable electronic device (insertable cardiac monitors are not&#xD;
             an exclusion criteria)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>35 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Pierre Ollitrault, MD, MSc</last_name>
    <phone>0231063106</phone>
    <email>ollitrault-p@chu-caen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <state>Normandy</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Ollitrault, MD, MSc</last_name>
      <phone>0231063106</phone>
      <email>ollitrault-p@chu-caen.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>September 3, 2020</study_first_submitted>
  <study_first_submitted_qc>February 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2021</study_first_posted>
  <last_update_submitted>February 25, 2021</last_update_submitted>
  <last_update_submitted_qc>February 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Lone Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

